NCT01764269View on ClinicalTrials.gov

Assessing Fever Rates in Children Ages 24 to 59 Months After Live Attenuated Influenza Vaccine (LAIV) or Inactivated Influenza Vaccines (IIV) Using Text Messaging for U.S. Influenza Vaccines in 2012-2013 & 2013-2014

NACompletedINTERVENTIONAL
Enrollment

656

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

May 31, 2014

Conditions
Fever
Interventions
OTHER

text message surveillance for fever

Trial Locations (2)

10032

Columbia University, New York

Unknown

Centers for Disease Control and Prevention, Atlanta

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

lead

Columbia University

OTHER

NCT01764269 - Assessing Fever Rates in Children Ages 24 to 59 Months After Live Attenuated Influenza Vaccine (LAIV) or Inactivated Influenza Vaccines (IIV) Using Text Messaging for U.S. Influenza Vaccines in 2012-2013 & 2013-2014 | Biotech Hunter | Biotech Hunter